<!DOCTYPE html>
<html lang="" xml:lang="">
<head>

  <meta charset="utf-8" />
  <meta http-equiv="X-UA-Compatible" content="IE=edge" />
  <title>FDCR biomarker domains, their definitions, and examples | Live FDCR Systematic Review</title>
  <meta name="description" content="<p>Twenty Years of Functional Magnetic Resonance Imaging
Current Status and Directions in Biomarker Development
with Cue-Reactivity Tasks in Addiction Medicine</p>" />
  <meta name="generator" content="bookdown 0.26 and GitBook 2.6.7" />

  <meta property="og:title" content="FDCR biomarker domains, their definitions, and examples | Live FDCR Systematic Review" />
  <meta property="og:type" content="book" />
  
  <meta property="og:description" content="<p>Twenty Years of Functional Magnetic Resonance Imaging
Current Status and Directions in Biomarker Development
with Cue-Reactivity Tasks in Addiction Medicine</p>" />
  <meta name="github-repo" content="mohsenebrahimyir/fdcr" />

  <meta name="twitter:card" content="summary" />
  <meta name="twitter:title" content="FDCR biomarker domains, their definitions, and examples | Live FDCR Systematic Review" />
  
  <meta name="twitter:description" content="<p>Twenty Years of Functional Magnetic Resonance Imaging
Current Status and Directions in Biomarker Development
with Cue-Reactivity Tasks in Addiction Medicine</p>" />
  

<meta name="author" content="Mohsen Ebrahimi" />


<meta name="date" content="2022-05-23" />

  <meta name="viewport" content="width=device-width, initial-scale=1" />
  <meta name="apple-mobile-web-app-capable" content="yes" />
  <meta name="apple-mobile-web-app-status-bar-style" content="black" />
  
  
<link rel="prev" href="four-major-steps-in-the-validation-of-fmri-drug-cue-reactivity-fdcr-derived-biomarkers.html"/>
<link rel="next" href="methods.html"/>
<script src="libs/jquery-3.6.0/jquery-3.6.0.min.js"></script>
<script src="https://cdn.jsdelivr.net/npm/fuse.js@6.4.6/dist/fuse.min.js"></script>
<link href="libs/gitbook-2.6.7/css/style.css" rel="stylesheet" />
<link href="libs/gitbook-2.6.7/css/plugin-table.css" rel="stylesheet" />
<link href="libs/gitbook-2.6.7/css/plugin-bookdown.css" rel="stylesheet" />
<link href="libs/gitbook-2.6.7/css/plugin-highlight.css" rel="stylesheet" />
<link href="libs/gitbook-2.6.7/css/plugin-search.css" rel="stylesheet" />
<link href="libs/gitbook-2.6.7/css/plugin-fontsettings.css" rel="stylesheet" />
<link href="libs/gitbook-2.6.7/css/plugin-clipboard.css" rel="stylesheet" />








<link href="libs/anchor-sections-1.1.0/anchor-sections.css" rel="stylesheet" />
<link href="libs/anchor-sections-1.1.0/anchor-sections-hash.css" rel="stylesheet" />
<script src="libs/anchor-sections-1.1.0/anchor-sections.js"></script>
<script src="libs/kePrint-0.0.1/kePrint.js"></script>
<link href="libs/lightable-0.0.1/lightable.css" rel="stylesheet" />
<!DOCTYPE HTML>

<link rel="preconnect" href="https://fonts.googleapis.com">
<link rel="preconnect" href="https://fonts.gstatic.com" crossorigin>
<link href="https://fonts.googleapis.com/css2?family=Roboto:wght@300&display=swap" rel="stylesheet">







<link rel="stylesheet" href="stl/style.css" type="text/css" />
</head>

<body>



  <div class="book without-animation with-summary font-size-2 font-family-1" data-basepath=".">

    <div class="book-summary">
      <nav role="navigation">

<ul class="summary">
<li><a href="./index.html">Live FDCR Systematic Review</a></li>

<li class="divider"></li>
<li class="chapter" data-level="" data-path="index.html"><a href="index.html"><i class="fa fa-check"></i>Authors</a></li>
<li class="chapter" data-level="" data-path="abstract.html"><a href="abstract.html"><i class="fa fa-check"></i>Abstract</a></li>
<li class="chapter" data-level="" data-path="introduction.html"><a href="introduction.html"><i class="fa fa-check"></i>Introduction</a>
<ul>
<li class="chapter" data-level="" data-path="four-major-steps-in-the-validation-of-fmri-drug-cue-reactivity-fdcr-derived-biomarkers.html"><a href="four-major-steps-in-the-validation-of-fmri-drug-cue-reactivity-fdcr-derived-biomarkers.html"><i class="fa fa-check"></i>Four major steps in the validation of fMRI drug cue reactivity (FDCR)-derived biomarkers</a></li>
<li class="chapter" data-level="" data-path="fdcr-biomarker-domains-their-definitions-and-examples.html"><a href="fdcr-biomarker-domains-their-definitions-and-examples.html"><i class="fa fa-check"></i>FDCR biomarker domains, their definitions, and examples</a></li>
</ul></li>
<li class="chapter" data-level="" data-path="methods.html"><a href="methods.html"><i class="fa fa-check"></i>Methods</a>
<ul>
<li class="chapter" data-level="" data-path="global-contribution-to-fmri-cue-reactivity-studies.html"><a href="global-contribution-to-fmri-cue-reactivity-studies.html"><i class="fa fa-check"></i>Global contribution to fMRI cue-reactivity studies</a></li>
<li class="chapter" data-level="" data-path="fmri-cue-reactivity-studies-across-years.html"><a href="fmri-cue-reactivity-studies-across-years.html"><i class="fa fa-check"></i>fMRI cue-reactivity studies across years</a></li>
<li class="chapter" data-level="" data-path="task-and-study-design-features-of-fmri-drug-cue-reactivity-studies.html"><a href="task-and-study-design-features-of-fmri-drug-cue-reactivity-studies.html"><i class="fa fa-check"></i>Task and study design features of fMRI drug cue reactivity studies</a></li>
<li class="chapter" data-level="" data-path="participants-in-fdcr-studies.html"><a href="participants-in-fdcr-studies.html"><i class="fa fa-check"></i>Participants in FDCR studies</a></li>
<li class="chapter" data-level="" data-path="biomarkers-in-fdcr-studies.html"><a href="biomarkers-in-fdcr-studies.html"><i class="fa fa-check"></i>Biomarkers in FDCR studies</a></li>
<li class="chapter" data-level="" data-path="interventional-fdcr-studies.html"><a href="interventional-fdcr-studies.html"><i class="fa fa-check"></i>Interventional FDCR studies</a></li>
</ul></li>
<li class="chapter" data-level="" data-path="descussion.html"><a href="descussion.html"><i class="fa fa-check"></i>Descussion</a>
<ul>
<li class="chapter" data-level="" data-path="preliminary-map-of-the-evidence-and-future-directions-in-biomarker-development.html"><a href="preliminary-map-of-the-evidence-and-future-directions-in-biomarker-development.html"><i class="fa fa-check"></i>Preliminary map of the evidence and future directions in biomarker development</a></li>
</ul></li>
<li class="chapter" data-level="" data-path="conclusion.html"><a href="conclusion.html"><i class="fa fa-check"></i>Conclusion</a></li>
<li class="chapter" data-level="" data-path="supplementary-tables-and-figures.html"><a href="supplementary-tables-and-figures.html"><i class="fa fa-check"></i>Supplementary Tables and Figures</a>
<ul>
<li class="chapter" data-level="" data-path="prisma-p-2015-flowchart.html"><a href="prisma-p-2015-flowchart.html"><i class="fa fa-check"></i>PRISMA-P 2015 Flowchart</a></li>
<li class="chapter" data-level="" data-path="multi-modal-correlations-in-fdcr-studies.html"><a href="multi-modal-correlations-in-fdcr-studies.html"><i class="fa fa-check"></i>Multi-modal correlations in FDCR studies</a></li>
<li class="chapter" data-level="" data-path="detailed-breakdown-of-interventional-fdcr-studies.html"><a href="detailed-breakdown-of-interventional-fdcr-studies.html"><i class="fa fa-check"></i>Detailed breakdown of interventional FDCR studies</a></li>
</ul></li>
<li class="chapter" data-level="" data-path="references.html"><a href="references.html"><i class="fa fa-check"></i>References</a></li>
<li class="divider"></li>
<li><a href="https://mohsenebrahimyir.github.com/fdcr/" target="blank">Live FDCR Systematic Review</a></li>

</ul>

      </nav>
    </div>

    <div class="book-body">
      <div class="body-inner">
        <div class="book-header" role="navigation">
          <h1>
            <i class="fa fa-circle-o-notch fa-spin"></i><a href="./">Live FDCR Systematic Review</a>
          </h1>
        </div>

        <div class="page-wrapper" tabindex="-1" role="main">
          <div class="page-inner">

            <section class="normal" id="section-">
<div id="fdcr-biomarker-domains-their-definitions-and-examples" class="section level2 hasAnchor">
<h2>FDCR biomarker domains, their definitions, and examples<a href="fdcr-biomarker-domains-their-definitions-and-examples.html#fdcr-biomarker-domains-their-definitions-and-examples" class="anchor-section" aria-label="Anchor link to header"></a></h2>
<table class=" lightable-classic table table-striped table-hover table-condensed table-responsive" style='font-family: "Arial Narrow", "Source Sans Pro", sans-serif; margin-left: auto; margin-right: auto; font-family: Roboto; '>
<caption>
<span id="tab:unnamed-chunk-4">Table 1: </span>
<strong>FDCR biomarker domains, their definitions, and examples.</strong>
Note that potential FDCR-derived safety biomarkers were
very rare in the database, and thus have not been included
as a separate category in other tables and figures.
</caption>
<thead>
<tr>
<th style="text-align:left;">
<strong>Biomarker Type</strong>
</th>
<th style="text-align:left;">
<strong>Description (Adapted from the BEST Glossary)</strong>
</th>
<th style="text-align:left;">
<strong>Examples</strong>
</th>
</tr>
</thead>
<tbody>
<tr>
<td style="text-align:left;">
<strong>Susceptibility</strong>
</td>
<td style="text-align:left;">
Indicates the potential for developing a disease or
medical condition in an individual who does not currently
have clinically apparent disease or the medical condition
</td>
<td style="text-align:left;">
Baseline cue-reactivity in the VMPFC, OFC, ACC,
striatum and insula predicts transitioning from
moderate to heavy drinking (Dager et al., 2014).
</td>
</tr>
<tr>
<td style="text-align:left;">
<strong>Diagnostic</strong>
</td>
<td style="text-align:left;">
Detects or confirms the presence of a disease or
condition of interest, or identifies individuals
with a subtype of the disease
</td>
<td style="text-align:left;">
<p><strong>SUDs vs. Healthy:</strong></p>
<ul>
<li>Individuals with cocaine use disorder show higher FDCR
compared to controls in the frontoparietal network
(Costumero et al., 2018)</li>
<li>Individuals with cocaine use disorder compared to
recreational stimulant users show greater orbitofrontal and
anterior cingulate FDCR during a cocaine-cue Stroop task
(Smith et al., 2014)</li>
</ul>
<p><strong>SUD Subtyping:</strong></p>
<ul>
<li><p>Among heavy alcohol drinkers, “relief” drinking
(due to negative reinforcement or habit)
compared to reward drinking (due to positive reinforcement)
is associated with greater dorsal striatal FDCR
(Burnette et al., 2021).</p></li>
<li><p>Individuals with cannabis use disorder and early-onset
cannabis use show FDCR in the dorsal striatum,
while those with late-onset use shoe FDCR in the ventral
striatum (Wetherill et al., 2016)</p>
</td>
</tr>
<tr>
<td style="text-align:left;">
<p><strong>Severity</strong></p>
</td>
<td style="text-align:left;">
<p>Is correlated with a disease indicator</p>
</td>
<td style="text-align:left;">
<p>In individuals with opioid use disorder, baseline FDCR in
the nucleus accumbens, orbitofrontal cortex and amygdala is
associated with drug use severity, and withdrawal symptoms
mediate the relationship between nucleus accumbens FDCR and
drug use severity (Shi et al., 2021).</p>
</td>
</tr>
<tr>
<td style="text-align:left;">
<p><strong>Prognostic</strong></p>
</td>
<td style="text-align:left;">
<p>Identifies the likelihood of a clinical event,
disease recurrence or progression in patients
who have the disease or medical condition of interest</p>
</td>
<td style="text-align:left;">
<p>Among individuals with stimulant use disorder, baseline FDCR
in the nucleus accumbens was prospectively associated with
time to relapse and could classify patients into those who
would relapse and those would not at 3 months after the scan,
with an accuracy outperforming predictions using conventional
measures (MacNiven et al., 2018).</p>
</td>
</tr>
<tr>
<td style="text-align:left;">
<p><strong>Monitoring</strong></p>
</td>
<td style="text-align:left;">
<p>Is measured repeatedly for assessing status of
a disease or medical condition or for evidence of
exposure to (or effect of) a medical product or
environmental agent</p>
</td>
<td style="text-align:left;">
<p><strong>Naturalistic Monitoring:</strong></p>
<ul>
<li><p>Among female cigarette smokers, frontal, temporal and
parietal regions show FDCR during the follicular phase of the
menstrual cycle but not the luteal phase
(Mendrek et al., 2014).</p></li>
<li><p>Among participants with internet gaming disorder followed
over one year, natural recovery from IGD was associated
with decreased anterior cingulate and lentiform FDCR and an
increase in cue-related effective ACC-lentiform connectivity
(Dong et al., 2019).</p></li>
</ul></li>
</ul>
<p><strong>Treatment Monitoring:</strong></p>
<ul>
<li>In a randomized placebo-controlled trial of individuals with
alcohol use disorder, naltrexone lowers ventral striatal FDCR
from baseline and more FDCR reduction was associated with a
greater clinical response (Schacht et al., 2017).
</td>
</tr>
<tr>
<td style="text-align:left;">
<strong>Predictive</strong>
</td>
<td style="text-align:left;">
Identifies individuals who are more likely than similar
individuals without the biomarker to experience a
favorable or unfavorable effect from exposure to a
medical product or environmental agent
</td>
<td style="text-align:left;">
<ul>
<li><p>In individuals with alcohol use disorder, the existence of
left putamen FDCR at baseline and the reduction of left
putamen FDCR early during treatment predict the effectiveness
of Naltrexone (Bach et al., 2020).</p></li>
<li><p>In individuals with alcohol use disorder, high baseline FDCR
in the ventral striatum can predict response to Naltrexone
(which reduces positive reinforcement and cue-reactivity)
but not Acamprosate (which inhibits negative reinforcement)
(Mann et al., 2014).
This finding has been directly replicated
(Bach et al., 2021).</p>
</td>
</tr>
<tr>
<td style="text-align:left;">
<p><strong>Response</strong></p>
</td>
<td style="text-align:left;">
<p>Shows that a biological response has occurred in an
individual who has been exposed to a medical product or
environmental agent</p>
</td>
<td style="text-align:left;">
<p><strong>Biological Response:</strong></p>
<ul>
<li>In a randomized placebo-controlled trial of individuals
with cocaine use disorder, modafinil acutely reduces FDCR in
the ventral tegmental area and increases FDCR in the anterior
cingulate and putamen, eliminating differences between
dependent participants and healthy controls
(Goudriaan et al., 2013).</li>
</ul></li>
</ul></li>
</ul>
<p><strong>Potential Surrogate Endpoint:</strong></p>
<ul>
<li>In a randomized sham-controlled trial of chronic smokers,
active versus sham tDCS over the dorsolateral prefrontal
cortex increases cue-related functional connectivity between
the dLPFC and the parahippocampus, and that this increase is
correlated with decreases in cigarette craving
(Yang et al., 2017).
</td>
</tr>
<tr>
<td style="text-align:left;">
<strong>Safety</strong>
</td>
<td style="text-align:left;">
Is measured before or after an exposure to a medical
product or an environmental agent to indicate the
likelihood, presence, or extent of toxicity as an
adverse effect
</td>
<td style="text-align:left;">
Contributing to discussions on the safety of electronic
cigarettes, FDCR has been used to show that e-cigarette
smoking may immediately increase FDCR
(Nichols et al., 2016).
Furthermore, sweet taste and nicotine content have
supra-additive influence on nucleus accumbens FDCR to the
sight and smell of e-cigarettes
(Kroemer et al., 2018).
</td>
</tr>
</tbody>
</table></li>
</ul>

</div>
<!-- </div> -->
            </section>

          </div>
        </div>
      </div>
<a href="four-major-steps-in-the-validation-of-fmri-drug-cue-reactivity-fdcr-derived-biomarkers.html" class="navigation navigation-prev " aria-label="Previous page"><i class="fa fa-angle-left"></i></a>
<a href="methods.html" class="navigation navigation-next " aria-label="Next page"><i class="fa fa-angle-right"></i></a>
    </div>
  </div>
<script src="libs/gitbook-2.6.7/js/app.min.js"></script>
<script src="libs/gitbook-2.6.7/js/clipboard.min.js"></script>
<script src="libs/gitbook-2.6.7/js/plugin-search.js"></script>
<script src="libs/gitbook-2.6.7/js/plugin-sharing.js"></script>
<script src="libs/gitbook-2.6.7/js/plugin-fontsettings.js"></script>
<script src="libs/gitbook-2.6.7/js/plugin-bookdown.js"></script>
<script src="libs/gitbook-2.6.7/js/jquery.highlight.js"></script>
<script src="libs/gitbook-2.6.7/js/plugin-clipboard.js"></script>
<script>
gitbook.require(["gitbook"], function(gitbook) {
gitbook.start({
"sharing": {
"github": false,
"facebook": false,
"twitter": true,
"linkedin": true,
"weibo": false,
"instapaper": false,
"vk": false,
"whatsapp": false,
"all": null
},
"fontsettings": {
"theme": "white",
"family": "sans",
"size": 2
},
"edit": {
"link": null,
"text": null
},
"history": {
"link": null,
"text": null
},
"view": {
"link": null,
"text": null
},
"download": null,
"search": {
"engine": "fuse",
"options": null
},
"toc": {
"collapse": "none"
},
"info": false
});
});
</script>

</body>

</html>
